Cystic fibrosis transmembrane conductance regulator (CFTR), a member of the ABC (ATP binding cassette) transporter family, is a chloride channel whose activity is controlled by protein kinase–dependent phosphorylation. Opening and closing (gating) of the phosphorylated CFTR is coupled to ATP binding and hydrolysis at CFTR's two nucleotide binding domains (NBD1 and NBD2). Recent studies present evidence that the open channel conformation reflects a head-to-tail dimerization of CFTR's two NBDs as seen in the NBDs of other ABC transporters (Vergani et al., 2005). Whether these two ATP binding sites play an equivalent role in the dynamics of NBD dimerization, and thus in gating CFTR channels, remains unsettled. Based on the crystal structures of NBDs, sequence alignment, and homology modeling, we have identified two critical aromatic amino acids (W401 in NBD1 and Y1219 in NBD2) that coordinate the adenine ring of the bound ATP. Conversion of the W401 residue to glycine (W401G) has little effect on the sensitivity of the opening rate to [ATP], but the same mutation at the Y1219 residue dramatically lowers the apparent affinity for ATP by >50-fold, suggesting distinct roles of these two ATP binding sites in channel opening. The W401G mutation, however, shortens the open time constant. Energetic analysis of our data suggests that the free energy of ATP binding at NBD1, but not at NBD2, contributes significantly to the energetics of the open state. This kinetic and energetic asymmetry of CFTR's two NBDs suggests an asymmetric motion of the NBDs during channel gating. Opening of the channel is initiated by ATP binding at the NBD2 site, whereas separation of the NBD dimer at the NBD1 site constitutes the rate-limiting step in channel closing.
Skip Nav Destination
Article navigation
1 October 2006
Article Contents
Article|
September 11 2006
The Two ATP Binding Sites of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Play Distinct Roles in Gating Kinetics and Energetics
Zhen Zhou,
Zhen Zhou
1Department of Medical Pharmacology and Physiology
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Search for other works by this author on:
Xiaohui Wang,
Xiaohui Wang
1Department of Medical Pharmacology and Physiology
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Search for other works by this author on:
Hao-Yang Liu,
Hao-Yang Liu
2Department of Biochemistry
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Search for other works by this author on:
Xiaoqin Zou,
Xiaoqin Zou
2Department of Biochemistry
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Search for other works by this author on:
Min Li,
Min Li
1Department of Medical Pharmacology and Physiology
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Search for other works by this author on:
Tzyh-Chang Hwang
Tzyh-Chang Hwang
1Department of Medical Pharmacology and Physiology
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Search for other works by this author on:
Zhen Zhou
1Department of Medical Pharmacology and Physiology
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Xiaohui Wang
1Department of Medical Pharmacology and Physiology
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Hao-Yang Liu
2Department of Biochemistry
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Xiaoqin Zou
2Department of Biochemistry
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Min Li
1Department of Medical Pharmacology and Physiology
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Tzyh-Chang Hwang
1Department of Medical Pharmacology and Physiology
3Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211
Correspondence to Tzyh-Chang Hwang: [email protected]
Z. Zhou and X. Wang contributed equally to this work.
Abbreviations used in this paper: CFTR, cystic fibrosis transmembrane conductance regulator; P-ATP, N6-(2-phenylethyl)-ATP; WT, wild type.
Received:
July 06 2006
Accepted:
August 24 2006
Online ISSN: 1540-7748
Print ISSN: 0022-1295
The Rockefeller University Press
2006
J Gen Physiol (2006) 128 (4): 413–422.
Article history
Received:
July 06 2006
Accepted:
August 24 2006
Citation
Zhen Zhou, Xiaohui Wang, Hao-Yang Liu, Xiaoqin Zou, Min Li, Tzyh-Chang Hwang; The Two ATP Binding Sites of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Play Distinct Roles in Gating Kinetics and Energetics . J Gen Physiol 1 October 2006; 128 (4): 413–422. doi: https://doi.org/10.1085/jgp.200609622
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
State-dependent modulation of CFTR gating by pyrophosphate
J Gen Physiol (March,2009)
A single amino acid substitution in CFTR converts ATP to an inhibitory ligand
J Gen Physiol (September,2014)
Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel
J Gen Physiol (April,2010)
Email alerts
Advertisement